Multiple Sclerosis Therapy Consensus Group (MSTCG): position statement on disease-modifying therapies for multiple sclerosis (white paper) von Wiendl, Heinz, Gold, Ralf, Berger, Thomas, Derfuss, Tobias, Linker, Ralf, Mäurer, Mathias, Aktas, Orhan, Baum, Karl, Berghoff, Martin, Bittner, Stefan, Chan, Andrew, Czaplinski, Adam, Deisenhammer, Florian, Di Pauli, Franziska, Du Pasquier, Renaud, Enzinger, Christian, Fertl, Elisabeth, Gass, Achim, Gehring, Klaus, Gobbi, Claudio, Goebels, Norbert, Guger, Michael, Haghikia, Aiden, Hartung, Hans-Peter, Heidenreich, Fedor, Hoffmann, Olaf, Kallmann, Boris, Kleinschnitz, Christoph, Klotz, Luisa, Leussink, Verena I., Leutmezer, Fritz, Limmroth, Volker, Lünemann, Jan D., Lutterotti, Andreas, Meuth, Sven G., Meyding-Lamadé, Uta, Platten, Michael, Rieckmann, Peter, Schmidt, Stephan, Tumani, Hayrettin, Weber, Frank, Weber, Martin S., Zettl, Uwe K., Ziemssen, Tjalf, Zipp, Frauke

Volltext

Non‐interventional, prospective, observational study on spasticity‐associated symptom control with nabiximols as add‐on therapy in patients with multiple sclerosis spasticity in Au... von Guger, Michael, Hatschenberger, Robert, Leutmezer, Fritz

Volltext

High efficacy of rituximab for myasthenia gravis: a comprehensive nationwide study in Austria von Topakian, Raffi, Zimprich, Fritz, Iglseder, Stephan, Embacher, Norbert, Guger, Michael, Stieglbauer, Karl, Langenscheidt, Dieter, Rath, Jakob, Quasthoff, Stefan, Simschitz, Philipp, Wanschitz, Julia, Windisch, David, Müller, Petra, Oel, Dierk, Schustereder, Günther, Einsiedler, Stefan, Eggers, Christian, Löscher, Wolfgang

Volltext

COVID-19 severity and mortality in multiple sclerosis are not associated with immunotherapy: Insights from a nation-wide Austrian registry von Bsteh, Gabriel, Assar, Hamid, Hegen, Harald, Heschl, Bettina, Leutmezer, Fritz, Di Pauli, Franziska, Gradl, Christiane, Traxler, Gerhard, Zulehner, Gudrun, Rommer, Paulus, Wipfler, Peter, Guger, Michael, Enzinger, Christian, Berger, Thomas

Volltext

Long‐term outcome after COVID‐19 infection in multiple sclerosis: A nation‐wide multicenter matched‐control study von Bsteh, Gabriel, Assar, Hamid, Gradl, Christiane, Heschl, Bettina, Hiller, Maria‐Sophie, Krajnc, Nik, Di Pauli, Franziska, Hegen, Harald, Traxler, Gerhard, Leutmezer, Fritz, Wipfler, Peter, Zulehner, Gudrun, Guger, Michael, Enzinger, Christian, Berger, Thomas, Doris, Aigner, Hamid, Assar, Thomas, Berger, Klaus, Böck, Christian, Bsteh, Gabriel, Bsteh, Pauli, Di, Christian, Enzinger, Christiane, Gradl, Elisabeth, Gruber, Michael, Guger, Harald, Hegen, Bettina, Heschl, Marie‐Sophie, Hiller, Barbara, Kornek, Heidi, Lemmerer, Fritz, Leutmezer, Camillo, Lex, Markus, Mayr, Gabriele, Morgenstern, Dirk, Oel, Paulus, Rommer, Peter, Schnabl, Gabriela, Schneider‐Koch, Gabriele, Schrotter, Gerhard, Traxler, Peter, Wipfler, Gudrun, Zulehner, Tobias, Zrzavy

Volltext

Cost-effectiveness of the Floodlight ® MS app in Austria. Unlocking the mystery of costs and outcomes of a digital health application for patients with multiple sclerosis von Walter, Evelyn, Traunfellner, Matthäus, Meyer, Franz, Enzinger, Christian, Guger, Michael, Bsteh, Christian, Altmann, Patrick, Hegen, Harald, Goger, Christoph, Mikl, Veronika

Volltext

Neuromyelitis optica in Austria in 2011: to bridge the gap between neuroepidemiological research and practice in a study population of 8.4 million people von Aboul-Enein, Fahmy, Seifert-Held, Thomas, Mader, Simone, Kuenz, Bettina, Lutterotti, Andreas, Rauschka, Helmut, Rommer, Paulus, Leutmezer, Fritz, Vass, Karl, Flamm-Horak, Agathe, Stepansky, Robert, Lang, Wilfried, Fertl, Elisabeth, Schlager, Thomas, Heller, Thomas, Eggers, Christian, Safoschnik, Georg, Fuchs, Siegrid, Kraus, Jörg, Assar, Hamid, Guggenberger, Stefan, Reisz, Martin, Schnabl, Peter, Komposch, Martina, Simschitz, Philipp, Skrobal, Alena, Moser, Alexander, Jeschow, Mario, Stadlbauer, Dorothea, Freimüller, Manfred, Guger, Michael, Schmidegg, Susanne, Franta, Claudia, Weiser, Vera, Koppi, Stefan, Niederkorn-Duft, Margret, Raber, Bettina, Schmeissner, Iris, Jecel, Julia, Tinchon, Alexander, Storch, Maria K, Reindl, Markus, Berger, Thomas, Kristoferitsch, Wolfgang

Volltext

Favorable benefit–risk ratio with teriflunomide treatment in relapsing-remitting multiple sclerosis: Results of the 2-year, multicenter, prospective, noninterventional TAURUS MS st... von Guger, Michael, Ackerl, Michael Matthias, Heine, Martin, Hofinger-Renner, Christiane, Spiss, Heinrich Karl, Taut, Andrea, Unger, Karin, Leutmezer, Fritz

Volltext

Functional Recovery in Autoimmune Encephalitis: A Prospective Observational Study von Seifert-Held, Thomas, Eberhard, Katharina, Lechner, Christian, Macher, Stefan, Hegen, Harald, Moser, Tobias, Jacob, Gregor Brecl, Puttinger, Gertraud, Topakian, Raffi, Guger, Michael, Kacar, Emrah, Zoche, Lea, De Simoni, Desiree, Seiser, Andreas, Oberndorfer, Stefan, Baumgartner, Christoph, Struhal, Walter, Zimprich, Friedrich, Sellner, Johann, Deisenhammer, Florian, Enzinger, Christian, Reindl, Markus, Rauschka, Helmut, Berger, Thomas, Höftberger, Romana

Volltext

Pregnancy Outcomes in Patients With Multiple Sclerosis Exposed to Natalizumab—A Retrospective Analysis From the Austrian Multiple Sclerosis Treatment Registry von Guger, Michael, Traxler, Gerhard, Drabauer, Martina, Leitner-Pohn, Doris, Enzinger, Christian, Leutmezer, Fritz, Oel, Dierk, Di Pauli, Franziska, Berger, Thomas, Ransmayr, Gerhard

Volltext

Diagnostik und Behandlung der Fatigue bei Multipler Sklerose von Guger, Michael

Volltext

Herausgeberbrief von Guger, Michael

Volltext

Multiple Sklerose und COVID-19 von Guger, Michael, Traxler, Gerhard

Volltext

Therapieoptionen bei Spastik in der MS-Therapie von Guger, Michael

Volltext

Tumefactive multiple sclerosis presents with painless progressive hemiparesis and aphasia von Guger, Michael, Ransmayr, Gerhard, Sonnberger, Michael, Hametner, Simon, Weis, Serge, Berger, Thomas, Enzinger, Christian

Volltext

Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis von Montalban, Xavier, Hauser, Stephen L, Kappos, Ludwig, Arnold, Douglas L, Bar-Or, Amit, Comi, Giancarlo, de Seze, Jérôme, Giovannoni, Gavin, Hartung, Hans-Peter, Hemmer, Bernhard, Lublin, Fred, Rammohan, Kottil W, Selmaj, Krzysztof, Traboulsee, Anthony, Sauter, Annette, Masterman, Donna, Fontoura, Paulo, Belachew, Shibeshih, Garren, Hideki, Mairon, Nicole, Chin, Peter, Wolinsky, Jerry S

Volltext

Early intensive versus escalation treatment in patients with relapsing–remitting multiple sclerosis in Austria von Guger, Michael, Enzinger, Christian, Leutmezer, Fritz, Di Pauli, Franziska, Kraus, Jörg, Kalcher, Stefan, Kvas, Erich, Berger, Thomas

Volltext

Switching from natalizumab to fingolimod treatment in multiple sclerosis: real life data from the Austrian MS Treatment Registry von Guger, Michael, Enzinger, Christian, Leutmezer, Fritz, Kraus, Jörg, Kalcher, Stefan, Kvas, Erich, Berger, Thomas

Volltext

Sex impacts treatment decisions in multiple sclerosis von Hegen, Harald, Berek, Klaus, Deisenhammer, Florian, Berger, Thomas, Enzinger, Christian, Guger, Michael, Kraus, Jörg, Walde, Janette, Di Pauli, Franziska

Volltext

Long-term outcome and predictors of long-term disease activity in natalizumab-treated patients with multiple sclerosis: real life data from the Austrian MS Treatment Registry von Guger, Michael, Enzinger, Christian, Leutmezer, Fritz, Di Pauli, Franziska, Kraus, Jörg, Kalcher, Stefan, Kvas, Erich, Berger, Thomas

Volltext